Components of Informed Consent: A Guide to Making a Choice
Informed consent is a conversation followed by a voluntary decision about a proposed treatment or research study. The elements of informed consent include understandable information, an opportunity to ask questions and a choice made without pressure. A signature records a decision; it does not establish that the person understood it.
Rules governing informed consent vary with the state, the decision and whether the activity is care or research. The practical starting point is the same: understand what is proposed, compare the available options and decide whether to agree.
What the conversation should cover
A clinician should explain the diagnosis or reason for a proposed test or treatment, what the intervention involves, its expected benefits and its material risks. The discussion should also cover reasonable alternatives, including what may happen if the person declines or waits. The American Medical Association’s guidance describes these elements as part of a conversation suited to the patient’s ability to understand.
The components of informed consent also include the person’s ability to make the particular decision and a voluntary choice. Capacity can depend on the decision and circumstances. A patient who needs an interpreter, plain-language explanation or more time can ask for those supports. A trusted person may join the discussion if the patient wishes.
The informed consent process can take more than one conversation. For example, a patient considering surgery may first discuss the diagnosis, then return with questions about recovery and non-surgical options. If important circumstances change before the procedure, the patient and clinician should discuss the new information and the choice again.
Compare choices before deciding
An alternative is meaningful when the person understands its likely consequences. For a proposed procedure, ask how much benefit is expected, how likely important complications are and how long recovery may take. Then ask the same questions about other reasonable treatments and about no immediate treatment. The clinician may not have exact numbers for every individual, but can explain what is known and what affects the estimate.
Consider the practical effects too: time away from work, help needed at home, follow-up visits and possible out-of-pocket costs. A choice that controls symptoms quickly may involve a longer recovery or different side effects than another option. The patient can explain which outcomes matter most and ask the clinician to connect those priorities to the alternatives.
A person with decision-making capacity may generally decline treatment, even when the clinician recommends it. MedlinePlus describes the right to refuse when the person understands the condition, options and risks and benefits. Asking what refusal or delay could mean helps make that decision concrete. If the explanation is unclear, the patient can ask the clinician to repeat it in different words and describe their own understanding back to the clinician.
Consent in research
Research aims to answer a question; the intervention being studied may or may not benefit an individual participant. Before agreeing, a prospective participant should understand the study’s purpose, expected duration, procedures, foreseeable risks, possible benefits and appropriate alternatives. Relevant information also includes how records will be handled, whom to contact with questions and what to do if a research-related injury occurs.
Under applicable federal protections, participation is voluntary, and a person can generally decline or withdraw without penalty or loss of benefits to which they are otherwise entitled. The Department of Health and Human Services explains that consent is an ongoing exchange, including a chance to ask questions. A participant considering withdrawal should ask the study team about safe steps for stopping an intervention, follow-up and the handling of information already collected.
A form is a reference and, when required, a record of agreement. Reading it alongside the discussion helps reveal questions that remain unanswered. Ask for a copy and keep the study contact information; signing should follow an opportunity to consider the decision.
Informed Consent Law and Special Situations
Informed consent law sets legal duties that depend on the jurisdiction and context. State rules can affect the information required for treatment, who may decide for a patient who lacks capacity and when a minor can consent. For a specific situation, the treating facility’s patient representative or a qualified local attorney can explain the applicable rules.
In an emergency, when a patient cannot decide and delay would threaten health, clinicians may provide necessary treatment under applicable emergency rules. If a patient lacks capacity in a nonemergency, an authorized surrogate may need to decide according to the relevant law and the patient’s known wishes. Federal research rules have distinct protections and limited exceptions; informed consent laws for ordinary clinical treatment should not be assumed to settle a research question.
Research informed consent requirements can also vary by the study and the regulations that apply. An institutional review board may approve a waiver in qualifying circumstances. The study team or its participant-rights contact can explain the protections and consent arrangements for a particular study.
Questions to keep handy
- What is proposed, why is it recommended, and what will happen during it?
- What benefits and risks matter most in this situation? How likely are they?
- What are the alternatives, including waiting or declining, and what could follow from each?
- How much time is available to decide, and who can answer further questions?
- For a study, what is research, how are records used, and what happens if participation stops?
